W. Robert Lee
Duke University
CancerInternal medicineRadiologyUrologySurgeryOncologyMedical physicsRadiation treatment planningExternal beam radiotherapyProstateBrachytherapyProstate brachytherapyProstatectomyMEDLINEProstate cancerProstate-specific antigenNuclear medicineRadiation oncologyRadiation therapyMedicine
168Publications
54H-index
5,071Citations
Publications 183
Newest
#7Joshua Siglin (Duke University)H-Index: 10
#8A.A. Solanki (Edward Hines, Jr. VA Hospital)
Source
#1Divya NatesanH-Index: 5
#2David J. CarpenterH-Index: 8
Last. Joseph K. SalamaH-Index: 46
view all 10 authors...
Source
#1Jinbing BaiH-Index: 12
#2Stephanie L. PughH-Index: 24
Last. Jeff M. MichalskiH-Index: 85
view all 20 authors...
Source
#1Rahul Khairnar (UMB: University of Maryland, Baltimore)H-Index: 6
#2Stephanie L. PughH-Index: 24
Last. Mark V. Mishra (UMB: University of Maryland, Baltimore)H-Index: 16
view all 23 authors...
PURPOSE The Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool are unknown, limiting our ability to perform cost-utility analyses. This study aimed to map EPIC tool to EuroQoL-5D-3L (EQ5D) to generate EQ5D health utilities. METHODS AND MATERIALS This is a secondary analysis of a prospective, randomized non-inf...
Source
#1Rahul Khairnar (Genentech)
#2Howard M. Sandler (Cedars-Sinai Medical Center)H-Index: 98
Last. Mark V. Mishra (UMB: University of Maryland, Baltimore)H-Index: 16
view all 20 authors...
60Background: Mapping algorithms informing economic evaluations are often derived using baseline data from clinical trials. It is unclear if these algorithms can predict health utilities accurately...
Source
#1Daniel E. Spratt (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 52
#2Shawn Malone (Ottawa Hospital)H-Index: 29
Last. Colleen A. Lawton (MCW: Medical College of Wisconsin)H-Index: 61
view all 20 authors...
5584Background: The timing of systemic therapy in relation to radiotherapy (RT) is important in most malignancies. In contrast, androgen deprivation therapy (ADT) has largely been investigated in r...
Source
#1James E. Bates (UF: University of Florida)H-Index: 11
#2Robert J. Amdur (UF: University of Florida)H-Index: 66
Last. W. Robert Lee (Duke University)H-Index: 54
view all 3 authors...
Source
Source
Source
#1Corbin D. Jacobs (Duke University)H-Index: 5
#2Jacob Trotter (Duke University)H-Index: 1
Last. Brian G. Czito (Duke University)H-Index: 31
view all 8 authors...
33Background: Synchronous prostate cancer (PC) and rectosigmoid (RS) cancer (RSC) is a challenging clinical situation. Methods: A retrospective review of Duke University and Durham VA charts was pe...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.